Dyspnea; Uremic, End Stage Renal Disease, Chronic Lung Disease, Chronic Heart Disease, Hemodialysis-Induced Symptom, Sodium Excess
Conditions
Keywords
Dyspnea, Hemodialysis, End Stage Renal Disease
Brief summary
Shortness of breath is very common among patients on dialysis for kidney failure; however, its causes are often not understood. This study will explore the lungs and the heart of these patients to determine the causes of shortness of breath. The amount of salt in the body tissues, which tends to accumulate in dialysis patients and can also cause shortness of breath, will also be measured. Machines that exploit magnetic resonance, ultrasound and x-rays to take images of the body interior will be employed; in addition, breathing tests, questionnaires and blood tests will also be used. 20 patients on dialysis will be recruited and have two visits: one at the beginning of the study and one year later to observe any changes in the lungs, heart and salt accumulation over time.
Detailed description
Rationale: The available evidence suggest that End-Stage Renal Disease (ESRD) and hemodialysis (HD) have harmful effects on the lungs; the investigators hypothesize that these recurring pulmonary insults, in an analogous way as recurring myocardial ischemic injury for the heart, cause long term impairment in the pulmonary parenchyma, airways and circulation. In addition, observational studies have reported that dyspnea is a common symptom among ESRD patients on chronic HD treatment; however, no study up to now has directly addressed the issue, so that the relationship between dyspnea and pulmonary involvement in the HD population remains poorly understood. The aim of this study is to explore the pathophysiological basis of dyspnea in patients with end stage renal disease on chronic HD, by using state-of-the-art imaging and functional study techniques. Study Design: This is an exploratory study involving a single center recruiting patients from the prevalent dialysis population of London, Ontario. 20 patients on maintenance hemodialysis will be recruited. The patients will undergo imaging, functional studies and blood sampling at the Robarts Research Institute on a non-dialysis day, during the short interval in the dialysis schedule, at baseline and after one year. Study Procedures: Blood Collection: blood will be collected from a venous access for standard-of-care tests, uremia and inflammation biomarkers. Dyspnea Assessment: dyspnea will be assessed with the following self-administered questionnaires: Modified Medical Research Council Breathlessness Scale, the University of California, San Diego Shortness of Breath Questionnaire Pulmonary Function Tests: spirometry and plethysmography pre and post salbutamol administration, carbon monoxide diffusion (DLCO) and the fractional exhaled nitric oxide (FeNO) will be evaluated. Six Minute Walk Test: the subjects able to do so will perform a six minute walk test, their dyspnea and overall fatigue at baseline and at the end of the exercise will be evaluated using the Borg Scale. Lung MRI: a proton MRI with ultrashort echo time (UTE) acquisition sequences for the study of lung parenchyma and lung water will be employed. Images will be acquired twice, both pre and post a bronchodilator (salbutamol) challenge. Sodium MRI: a proton T1 weighted fast-low-angle-shot (FLASH)- sequence will be acquired to delineate the anatomy of the lower leg. Then, a sodium MRI study of the subjects' legs (\ 5 cm below the knee) will be obtained with the custom-made sodium coil at 3.0 Tesla. Water content will also be quantified using proton-MRI with fat-suppressed inversion recovery sequence with proton density contrast. Chest CT: a high-resolution chest CT scan will be performed using a 64-slice CT scanner. A low radiation dose protocol will be employed. A qualitative and quantitative evaluation of pulmonary airways, blood vessels and parenchyma will be performed. 2D Transthoracic Echocardiography: images will be taken in the left lateral decubitus. Images and loops from standard parasternal long axis and short axis, subcostal, apical 4, 2 and 3- chamber views will be recorded and analyzed for: global longitudinal strain, left ventricular ejection fraction, left ventricular mass, left atrial volume, right ventricular diameter, right atrial volume, right ventricular wall thickness, tricuspid annular plane systolic excursion, pulmonary artery systolic pressure, E/A ratio, E/E' ratio at the basal interventricular septum, aortic, mitral, tricuspid and pulmonary valve qualitative and quantitative function.
Interventions
DIAGNOSTIC_TESTLung MRI
Proton Lung Magnetic Resonance Imaging
DIAGNOSTIC_TESTSodium MRI
Sodium Soft Tissue Magnetic Resonance Imaging
DIAGNOSTIC_TESTChest CT
High-resolution Quantitative Chest CT
DIAGNOSTIC_TESTEchocardiography
Transthoracic 2D Speckle-Tracking Echocardiography
DIAGNOSTIC_TESTFractional Exhaled Nitric Oxide
Fractional Exhaled Nitric Oxide testing
DIAGNOSTIC_TESTPulmonary Function Tests
Spirometry and Plethysmography
DIAGNOSTIC_TESTBlood Sampling
Blood testing for: standard-of-care, inflammatory biomarkers, uremic toxins
DIAGNOSTIC_TESTSix-Minute Walk Test
Six-Minute Walk Test
DIAGNOSTIC_TESTDyspnea Questionnaires
Modified Medical Research Council; University of California, San Diego Shortness of Breath Questionnaire; Borg Scale
Sponsors
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age equal to or greater than 18 years. * Dialysis vintage equal to or greater than 3 months.
Exclusion criteria
* Smoking history of more than 10 packs/year. * Active tobacco and/or cannabis smoking. * Diagnosed chronic pulmonary disease. * Severe heart failure (NYHA class IV) * Active infection (including tuberculosis) or malignancy. * Pregnancy. * Inability to give consent or understand written information. * Peripheral oxygen saturation (by pulse oxymetry) dropping below 80% when performing a 12-seconds breathhold. * Inability to perform spirometry or plethysmography maneuvers. * Inability to tolerate MRI due to patient size and/or known history of claustrophobia. * Subject has an implanted mechanically, electrically or magnetically activated device or any metal in their body which cannot be removed, including but not limited to pacemakers, neurostimulators, biostimulators, implanted insulin pumps, aneurysm clips, bioprosthesis, artificial limb, metallic fragment or foreign body, shunt, surgical staples (including clips or metallic sutures and/or ear implants.).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Baseline Modified Medical Research Council scale score. | Baseline | Baseline dyspnea measured by Modified Medical Research Council scale. 0-4 from lowest (no dyspnea) to highest (most severe dyspnea). |
| Baseline University of California, San Diego Shortness of Breath Questionnaire score. | Baseline | Baseline dyspnea measured by University of California, San Diego Shortness of Breath Questionnaire. 0-120 from lowest (no dyspnea) to highest (most severe dyspnea). |
| Baseline pulmonary artery diameter. | Baseline | Baseline pulmonary artery diameter (in millimeters) by chest Computed Tomography. |
| Baseline lung total blood vessel volume. | Baseline | Baseline lung total blood vessel volume in ml by chest Computed Tomography. |
| Baseline lung total airway count. | Baseline | Baseline lung total airway count by chest Computed Tomography. |
| Baseline lung low attenuation area. | Baseline | Baseline lung low attenuation area by chest Computed Tomography. |
| Baseline lung water content. | Baseline | Baseline lung water content in arbitrary units measured by proton Magnetic Resonance Imaging. |
| Baseline soft tissue sodium content. | Baseline | Baseline soft tissue sodium content in mmol/L measured by sodium Magnetic Resonance Imaging. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Correlation between modified Medical Research Council scale score and lung total water content. | Baseline and one year | Correlation coefficient between modified Medical Research Council scale score and lung total water content (in arbitrary units), measured by proton Magnetic Resonance Imaging. |
| One year changes in University of California, San Diego Shortness of Breath Questionnaire score. | Baseline and one year | Comparison of dyspnea measured by University of California, San Diego Shortness of Breath Questionnaire at one year versus baseline. 0-120 from lowest (no dyspnea) to highest (most severe dyspnea). |
| Correlation between baseline University of California, San Diego Shortness of Breath Questionnaire score and one year morbidity. | Baseline and one year | One year morbidity risk by University of California, San Diego Shortness of Breath Questionnaire baseline score. |
| Correlation between baseline University of California, San Diego Shortness of Breath Questionnaire score and one year mortality. | Baseline and one year | One year mortality risk by University of California, San Diego Shortness of Breath Questionnaire baseline score. |
| Correlation between University of California, San Diego Shortness of Breath Questionnaire score and pulmonary artery diameter. | Baseline and one year | Correlation coefficient between University of California, San Diego Shortness of Breath Questionnaire score and pulmonary artery diameter (in millimeters), measured by chest Computed Tomography. |
| Correlation between University of California, San Diego Shortness of Breath Questionnaire score and soft tissue sodium content. | Baseline and one year | Correlation coefficient between soft tissue sodium content (mmol/L) and University of California, San Diego Shortness of Breath Questionnaire score. |
| Correlation between University of California, San Diego Shortness of Breath Questionnaire score and lung total blood vessel volume. | Baseline and one year | Correlation coefficient between University of California, San Diego Shortness of Breath Questionnaire score and lung total blood vessel volume (in milliliters), measured by chest Computed Tomography. |
| Correlation between University of California, San Diego Shortness of Breath Questionnaire score and lung total airway count. | Baseline and one year | Correlation coefficient between University of California, San Diego Shortness of Breath Questionnaire score and lung total airway count, measured by chest Computed Tomography. |
| Correlation between University of California, San Diego Shortness of Breath Questionnaire score and lung low attenuation areas. | Baseline and one year | Correlation coefficient between University of California, San Diego Shortness of Breath Questionnaire score and lung low attenuation areas, measured by chest Computed Tomography. |
| Correlation between University of California, San Diego Shortness of Breath Questionnaire score and lung total water content. | Baseline and one year | Correlation coefficient between University of California, San Diego Shortness of Breath Questionnaire score and lung total water content (in arbitrary units), measured by proton Magnetic Resonance Imaging. |
| One year changes in lung total blood vessel volume. | Baseline and one year | Comparison of lung total blood vessel volume (in milliliters) at one year versus baseline, measured by chest Computed Tomography. |
| One year changes in lung total airway count. | Baseline and one year | Comparison of lung total airway count at one year versus baseline, measured by chest Computed Tomography. |
| One year changes in lung water content. | Baseline and one year | Comparison of lung water content (in arbitrary units) at one year versus baseline, measured by proton Magnetic Resonance Imaging. |
| One year changes in lung low attenuation areas. | Baseline and one year | Comparison of lung low attenuation areas at one year versus baseline, measured by chest Computed Tomography. |
| One year changes in pulmonary artery diameter. | Baseline and one year | Comparison of pulmonary artery diameter (in millimeters) at one year versus baseline, measured by chest Computed Tomography. |
| Baseline pulmonary artery systolic pressure. | Baseline | Baseline pulmonary artery systolic pressure (in mmHg), measured by transthoracic doppler echocardiography. |
| One year changes in pulmonary artery systolic pressure. | Baseline and one year | Comparison of pulmonary artery systolic pressure in mmHg at one year versus baseline, measured by transthoracic doppler echocardiography. |
| Baseline fractional exhaled nitric oxide. | Baseline | Baseline fractional exhaled nitric oxide measured (in parts per billion). |
| One year changes in Modified Medical Research Council scale score. | Baseline and one year | Comparison of dyspnea measured by Modified Medical Research Council scale at one year versus baseline. 0-4 from lowest (no dyspnea) to highest (most severe dyspnea). |
| Baseline forced expiratory volume at one second/forced vital capacity ratio. | Baseline | Baseline forced expiratory volume at one second/forced vital capacity ratio by pulmonary function tests. |
| One year changes in forced expiratory volume at one second/forced vital capacity ratio. | Baseline and one year | Comparison of forced expiratory volume at one second/forced vital capacity ratio at one year versus baseline, by pulmonary function tests. |
| Baseline diffusing capacity of the lung for carbon monoxide. | Baseline | Baseline diffusing capacity of the lung for carbon monoxide (in ml/min/kPa), by pulmonary function tests. |
| One year changes in diffusing capacity of the lung for carbon monoxide. | Baseline and one year | Comparison of diffusing capacity of the lung for carbon monoxide (in ml/min/kPa) at one year versus baseline, by pulmonary function tests |
| Baseline six minute walk distance. | Baseline | Baseline six minute walk distance (in meters) measured by six minute walk test. |
| One year changes in six minute walk distance. | Baseline and one year | Comparison of six minute walk distance (in meters) at one year versus baseline, measured by six minute walk test. |
| One year changes in soft tissue sodium content. | Baseline and one year | Comparison of soft tissue sodium content (in mmol/L) at one year versus baseline, measured by sodium Magnetic Resonance Imaging. |
| One year changes in fractional exhaled nitric oxide. | Baseline and one year | Comparison of fractional exhaled nitric oxide measured (in parts per billion) at one year versus baseline. |
| Correlation between baseline modified Medical Research Council scale score and one year morbidity. | Baseline and one year | One year morbidity risk by modified Medical Research Council scale baseline score. |
| Correlation between baseline modified Medical Research Council scale score and one year mortality. | Baseline and one year | One year mortality risk by modified Medical Research Council scale baseline score. |
| Correlation between modified Medical Research Council scale score and soft tissue sodium content. | Baseline and one year | Correlation coefficient between soft tissue sodium content (mmol/L) and modified Medical Research Council scale score. |
| Correlation between modified Medical Research Council scale score and pulmonary artery diameter. | Baseline and one year | Correlation coefficient between modified Medical Research Council scale score and pulmonary artery diameter (in millimeters), measured by chest Computed Tomography. |
| Correlation between modified Medical Research Council scale score and lung total blood vessel volume. | Baseline and one year | Correlation coefficient between modified Medical Research Council scale score and lung total blood vessel volume (in milliliters), measured by chest Computed Tomography. |
| Correlation between modified Medical Research Council scale score and lung total airway count. | Baseline and one year | Correlation coefficient between modified Medical Research Council scale score and lung total airway count, measured by chest Computed Tomography. |
| Correlation between modified Medical Research Council scale score and lung low attenuation areas. | Baseline and one year | Correlation coefficient between modified Medical Research Council scale score and lung low attenuation areas, measured by chest Computed Tomography. |
Countries
Canada
Outcome results
None listed